Robot-assisted surgery had longer operative duration than laparoscopy, but no obvious difference compared to open surgery<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, June 28, 2021 (HealthDay News) — For adults undergoing abdominopelvic surgery, robot-assisted surgery currently offers no clear advantage over laparoscopy or open surgery, and it increases operative duration compared with laparoscopy, according to a systematic review published online June 29 in the Annals of Internal Medicine<\/em>.<\/p>\n Naila H. Dhanani, M.D., from McGovern Medical School at UTHealth in Houston, and colleagues examined the quality of evidence and outcomes of robot-assisted surgery compared with laparoscopy and open surgery in a review of 50 studies with 4,898 patients undergoing abdominopelvic surgery.<\/p>\n The researchers found that four (10 percent) of the 39 studies that reported incidence of Clavien-Dindo complications showed fewer complications with robot-assisted surgery. No difference was seen in intraoperative complications, conversion rates, or long-term outcomes in the majority of studies. Compared with laparoscopy, robot-assisted surgery had longer operative duration, but no obvious difference was seen compared with open surgery.<\/p>\n “Robot-assisted surgery has established itself as safe and effective but has not yet shown clear clinical benefit over either laparoscopy or open surgery. It comes at a substantial economic price and with significantly longer operative duration,” the authors write. “However, with increased competition, improved technology and cost, and greater overall experience, robot-assisted surgery has the potential to evolve into a transformative innovation.”<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n